Silo Pharma, Inc. Stock Analysis & AI Score
Silo Pharma, Inc. (SILO) has an ST Score of 27.4 (D+), driven by its Financial Strength (B) and held back by its Momentum (D-). SILO last traded at $1.75.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Silo Pharma, Inc. (SILO) has an ST Score of 27.4 (D+), driven by its Financial Strength (B) and held back by its Momentum (D-). SILO last traded at $1.75.
- Strongest
- Financial StrengthB
- Weakest
- MomentumD-
All factor grades
- Financial StrengthB
- ValuationC
- GrowthC-
- ProfitabilityD-
- MomentumD-
- Piotroski1/9
Contact
SILO stock: frequently asked questions
What is SILO's ST Score?
Silo Pharma, Inc. (SILO) has an ST Score of 27.4 (D+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SILO a buy, hold, or sell?
Our ST Score grades it D+ (27.4/100). The ST Score is a data-driven signal, not a recommendation.
What are SILO's factor grades?
Valuation C, Profitability D-, Financial Strength B, Momentum D-, Growth C-.
What is SILO's valuation grade?
Silo Pharma, Inc. (SILO) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SILO's growth grade?
Silo Pharma, Inc. (SILO) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SILO's profitability grade?
Silo Pharma, Inc. (SILO) earns a profitability grade of D-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SILO's financial strength grade?
Silo Pharma, Inc. (SILO) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is SILO's Piotroski score?
Silo Pharma, Inc. (SILO) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.